We are evaluating AVITI as a new sequencing platform. If it really provides >Q40 compared to Q30 then we could sequence more shallowly to call variants, identify more subpopulations at the same read depth etc.... So it would be cost-saving for our customers even if per read cost is identical to Illumina. This is why I think the absolute values I get out are important (not the difference, or marginal distributions). This is also what the marketing hype is about.
The BSQR curve that is shown looks the same for 10M, 50M, 100M and 200M reads. I don't understand what additional information I get from checking marginal distributions if the corrected maximum value is 31. It tells me that at the same read depth, I can expect the same accuracy for calling SNPs as with Illumina (of course the error profile might differ a bit). Which is fine, but it's not what is advertised.
Can you try this as an alternate? From BBTools.
It can then be used to recalibrate data.